RMD insider buying and SEC filings, explained
Resmed Inc. · CIK 943819
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Company profile
- Exchanges
- NYSE, OTC
- Industry (SIC)
- Surgical & Medical Instruments & Apparatus
- State of incorporation
- DE
- Fiscal year end
- Jun 30
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$0
Planned sales (10b5-1)
$22.4M
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Oct 23, 2026 | Planned (10b5-1) | Michael J Rider (Global General Counsel) sold 400 shares at $255.00 ($102K), marked as a 10b5-1 plan trade. Holdings down 3% to 12,318 shares. | SEC filing Filed Oct 26, 2026, 3:39 PM ET |
| Oct 7, 2026 | Planned (10b5-1) | Michael J. Farrell (CEO and Director) sold 4,991 shares at about $226.33 ($1.1M), marked as a 10b5-1 plan trade. Holdings down 1% to 479,803 shares. | SEC filing Filed Oct 8, 2026, 5:31 PM ET |
| Sep 8, 2026 | Planned (10b5-1) | Michael J. Farrell (CEO and Director) sold 4,991 shares at about $222.44 ($1.1M), marked as a 10b5-1 plan trade. Holdings down 1% to 466,256 shares. | SEC filing Filed Sep 10, 2026 |
| Sep 2, 2026 | Planned (10b5-1) | Peter C. Farrell (Director) sold 970 shares at $234.73 ($228K), marked as a 10b5-1 plan trade. Holdings down 2% to 51,803 shares. | SEC filing Filed Sep 4, 2026 |
| Aug 7, 2026 | Planned (10b5-1) | Michael J. Farrell (CEO and Director) sold 4,991 shares at about $205.69 ($1.0M), marked as a 10b5-1 plan trade. Holdings down 1% to 466,256 shares. | SEC filing Filed Aug 11, 2026 |
| Aug 5, 2026 | Planned (10b5-1) | Peter C. Farrell (Director) sold 8,000 shares at $225.00 ($1.8M), marked as a 10b5-1 plan trade. Holdings down 13% to 52,773 shares. | SEC filing Filed Aug 6, 2026 |
| Jul 7, 2026 | Planned (10b5-1) | Michael J. Farrell (CEO and Director) sold 4,991 shares at about $218.55 ($1.1M), marked as a 10b5-1 plan trade. Holdings down 1% to 466,223 shares. | SEC filing Filed Jul 9, 2026 |
| Jun 8, 2026 | Planned (10b5-1) | Michael J. Farrell (CEO and Director) sold 4,991 shares at about $193.96 ($968K), marked as a 10b5-1 plan trade. Holdings down 1% to 466,256 shares. | SEC filing Filed Jun 9, 2026 |
| May 7, 2026 | Planned (10b5-1) | Michael J. Farrell (CEO and Director) sold 4,991 shares at about $207.82 ($1.0M), marked as a 10b5-1 plan trade. Holdings down 1% to 466,223 shares. | SEC filing Filed May 11, 2026 |
| Apr 7, 2026 | Planned (10b5-1) | Michael J. Farrell (CEO and Director) sold 4,991 shares at about $225.50 ($1.1M), marked as a 10b5-1 plan trade. Holdings down 1% to 466,223 shares. | SEC filing Filed Apr 9, 2026 |
| Apr 1, 2026 | Planned (10b5-1) | Brett Sandercock (CFO) sold 1,000 shares at $224.31 ($224K), marked as a 10b5-1 plan trade. Holdings down 1% to 83,495 shares. | SEC filing Filed Apr 3, 2026 |
| Apr 1, 2026 | Planned (10b5-1) | Peter C. Farrell (Director) sold 2,000 shares at $225.00 ($450K), marked as a 10b5-1 plan trade. Holdings down 3% to 60,773 shares. | SEC filing Filed Apr 2, 2026 |
| Mar 9, 2026 | Planned (10b5-1) | Michael J. Farrell (CEO and Director) sold 4,991 shares at about $251.03 ($1.3M), marked as a 10b5-1 plan trade. Holdings down 1% to 466,223 shares. | SEC filing Filed Mar 11, 2026 |
| Mar 4, 2026 | Planned (10b5-1) | Peter C. Farrell (Director) sold 2,000 shares at $260.22 ($520K), marked as a 10b5-1 plan trade. Holdings down 3% to 62,773 shares. | SEC filing Filed Mar 5, 2026 |
| Mar 2, 2026 | Planned (10b5-1) | Brett Sandercock (CFO) sold 1,000 shares at $254.30 ($254K), marked as a 10b5-1 plan trade. Holdings down 1% to 84,495 shares. | SEC filing Filed Mar 3, 2026 |
| Feb 9, 2026 | Planned (10b5-1) | Michael J. Farrell (CEO and Director) sold 4,991 shares at about $273.78 ($1.4M), marked as a 10b5-1 plan trade. Holdings down 1% to 466,223 shares. | SEC filing Filed Feb 10, 2026 |
| Feb 4, 2026 | Planned (10b5-1) | Peter C. Farrell (Director) sold 2,000 shares at $251.31 ($503K), marked as a 10b5-1 plan trade. Holdings down 3% to 64,773 shares. | SEC filing Filed Feb 6, 2026 |
| Feb 4, 2026 | Planned (10b5-1) | Michael J Rider (Global General Counsel) sold 50 shares at $260.00 ($13K), marked as a 10b5-1 plan trade. Holdings down 1% to 9,691 shares. | SEC filing Filed Feb 6, 2026 |
| Feb 2, 2026 | Planned (10b5-1) | Brett Sandercock (CFO) sold 1,000 shares at $257.03 ($257K), marked as a 10b5-1 plan trade. Holdings down 1% to 85,495 shares. | SEC filing Filed Feb 3, 2026 |
| Jan 7, 2026 | Planned (10b5-1) | Peter C. Farrell (Director) sold 2,000 shares at $248.83 ($498K), marked as a 10b5-1 plan trade. Holdings down 3% to 66,773 shares. | SEC filing Filed Jan 9, 2026 |
| Jan 7, 2026 | Planned (10b5-1) | Michael J. Farrell (CEO and Director) sold 4,991 shares at about $248.46 ($1.2M), marked as a 10b5-1 plan trade. Holdings down 1% to 466,223 shares. | SEC filing Filed Jan 8, 2026 |
| Jan 2, 2026 | Planned (10b5-1) | Brett Sandercock (CFO) sold 1,000 shares at $241.75 ($242K), marked as a 10b5-1 plan trade. Holdings down 1% to 86,495 shares. | SEC filing Filed Jan 5, 2026 |
| Jan 2, 2026 | Planned (10b5-1) | Michael J Rider (Global General Counsel) sold 50 shares at $241.75 ($12K), marked as a 10b5-1 plan trade. Holdings down 1% to 9,741 shares. | SEC filing Filed Jan 5, 2026 |
| Dec 8, 2025 | Planned (10b5-1) | Michael J. Farrell (CEO and Director) sold 4,991 shares at about $251.41 ($1.3M), marked as a 10b5-1 plan trade. Holdings down 1% to 466,223 shares. | SEC filing Filed Dec 9, 2025 |
| Dec 3, 2025 | Planned (10b5-1) | Peter C. Farrell (Director) sold 2,000 shares at $251.47 ($503K), marked as a 10b5-1 plan trade. Holdings down 3% to 68,773 shares. | SEC filing Filed Dec 4, 2025 |
| Dec 1, 2025 | Planned (10b5-1) | Michael J Rider (Global General Counsel) sold 50 shares at $244.16 ($12K), marked as a 10b5-1 plan trade. Holdings down 1% to 9,791 shares. | SEC filing Filed Dec 2, 2025 |
| Dec 1, 2025 | Planned (10b5-1) | Brett Sandercock (CFO) sold 1,000 shares at $244.16 ($244K), marked as a 10b5-1 plan trade. Holdings down 1% to 87,495 shares. | SEC filing Filed Dec 2, 2025 |
| Nov 25, 2025 | Planned (10b5-1) | Witte Jan De (Director) sold 2,055 shares at $255.00 ($524K), marked as a 10b5-1 plan trade. Holdings down 33% to 4,261 shares. | SEC filing Filed Nov 26, 2025 |
| Nov 12, 2025 | Planned (10b5-1) | Peter C. Farrell (Director) sold 2,000 shares at $252.05 ($504K), marked as a 10b5-1 plan trade. Holdings down 3% to 66,110 shares. | SEC filing Filed Nov 13, 2025 |
| Nov 11, 2025 | Planned (10b5-1) | Witte Jan De (Director) sold 487 shares at $250.25 ($122K), marked as a 10b5-1 plan trade. Holdings down 8% to 5,319 shares. | SEC filing Filed Nov 13, 2025 |
| Nov 7, 2025 | Planned (10b5-1) | Michael J. Farrell (CEO and Director) sold 8,011 shares at about $249.75 ($2.0M), marked as a 10b5-1 plan trade. Holdings down 2% to 467,866 shares. | SEC filing Filed Nov 10, 2025 |
| Nov 3, 2025 | Planned (10b5-1) | Brett Sandercock (CFO) sold 3,000 shares at $247.54 ($743K), marked as a 10b5-1 plan trade. Holdings down 3% to 85,745 shares. | SEC filing Filed Nov 4, 2025 |
40 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
| Filed | Items | Tag | Source |
|---|---|---|---|
| Oct 29, 2026, 4:05 PM ET 8-K | Earnings released (Item 2.02) Other event (Item 8.01) | SEC filing |
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow RMD in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.